BCM
GSK icon

Boltwood Capital Management’s GSK GSK Stock Holding History

Boltwood Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$684K Buy
13,053
+665
+5% +$35.2K 0.16% 122
2026
Q1 		$684K Buy
12,388
+365
+3% +$19.8K 0.17% 105
2025
Q4 		$590K Sell
12,023
-15
-0.1% -$700 0.15% 118
2025
Q3 		$520K Buy
12,038
+45
+0.4% +$1.76K 0.14% 124
2025
Q2 		$461K Buy
11,993
+5
+0% +$191 0.13% 130
2025
Q1 		$464K Sell
11,988
-465
-4% -$17K 0.14% 124
2024
Q4 		$421K Buy
12,453
+1,120
+10% +$40.3K 0.13% 125
2024
Q3 		$463K Buy
11,333
+200
+2% +$8.18K 0.14% 124
2024
Q2 		$429K Buy
11,133
+270
+2% +$11.4K 0.13% 125
2024
Q1 		$466K Buy
10,863
+210
+2% +$8.66K 0.14% 119
2023
Q4 		$395K Buy
10,653
+865
+9% +$31.1K 0.13% 123
2023
Q3 		$355K Buy
9,788
+175
+2% +$6.21K 0.13% 120
2023
Q2 		$343K Buy
9,613
+190
+2% +$6.82K 0.12% 127
2023
Q1 		$335K Buy
9,423
+2,480
+36% +$86.8K 0.13% 126
2022
Q4 		$244K Buy
+6,943
New +$231K 0.1% 135
2022
Q2 		– Sell
-6,805
Closed -$371K – 153
2022
Q1 		$371K Buy
6,805
+11
+0.2% +$597 0.14% 126
2021
Q4 		$374K Sell
6,794
-64
-0.9% -$3.33K 0.14% 124
2021
Q3 		$328K Buy
6,858
+594
+9% +$29.8K 0.13% 129
2021
Q2 		$312K Buy
6,264
+465
+8% +$22.3K 0.13% 132
2021
Q1 		$259K Buy
5,799
+965
+20% +$43.8K 0.12% 136
2020
Q4 		$222K Sell
4,834
-11,351
-70% -$521K 0.11% 137
2020
Q3 		$761K Buy
16,185
+200
+1% +$10K 0.42% 78
2020
Q2 		$815K Buy
15,985
+293
+2% +$15K 0.49% 70
2020
Q1 		$743K Buy
+15,692
New +$837K 0.53% 67

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

Boltwood Capital Management's GSK Position: Q2 2026 in Review

Boltwood Capital Management increased its GSK (GSK) stake by 5.4% in Q2 2026, buying an estimated $35.2K and bringing the position to 13,053 shares worth $684K. The position accounts for 0.16% of the portfolio, ranked #122.

Boltwood Capital Management first reported a position in GSK in Q1 2020 and has held it in 24 quarters since. The position peaked at $815K in Q2 2020. 186 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Boltwood Capital Management held 13,053 shares of GSK worth $684K as of Q2 2026.
  • Boltwood Capital Management bought 665 GSK shares in Q2 2026, an estimated $35.2K.
  • GSK made up 0.16% of Boltwood Capital Management's portfolio in Q2 2026, its #122 holding.
  • Boltwood Capital Management first reported a position in GSK in Q1 2020 and has held it in 24 quarters since.
  • Boltwood Capital Management's GSK position peaked at $815K in Q2 2020.
  • 186 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Boltwood Capital Management's 13F filing for Q2 2026, filed 6 Jul 2026.